Benchmark Holdings PLC, the international animal health, technical publishing and sustainability science business, announces that its Animal Health division has entered into an agreement with Saiba Animal Health AG (“Saiba Animal Health”). With an estimated 10% of the global population suffering from cat allergies, the agreement between Saiba Animal Health and Benchmark is designed to …Read More
Archive: September 1, 2014
- Saiba Animal Health AG enters into an Agreement with Boehringer Ingelheim
- Saiba Animal Health led consortium receives top ranking and funding from Eurostars Program for the research and development of a vaccine for African Swine Fever.
- Saiba Animal Health Enters Into an Agreement with a Major Animal Health Company
- Key preclinical data for Saiba Animal Health’s cat allergy vaccine (HypoCat™ / VC001) published in leading allergy journal.
- Saiba Animal Health AG today announced the publication of proof of principle data for a vaccine with the potential to translate into a novel therapy for osteoarthritic pain in companion animals